Ibritumomab vs Denosumab

Interacting Drugs
Ibritumomab
vs
Denosumab
Security Level
Minor, Monitor Therapy
Mechanism
Denosumab: May enhance the adverse/toxic effect of Immunosuppressants. Specifically, the risk for serious infections may be increased.
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Ibritumomab vs Denosumab


Other Interactions of Ibritumomab

We are Developing Our database, More results coming soon.